Chemotherapy in Treating Patients With Prostate Cancer

Completed · Phase 2

Conditions studied: Prostate Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of DX-8951f in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.

Key facts

Study ID

NCT00004045

Run by

Daiichi Sankyo

Starts

1999-06-01

Expected to finish

2001-08-01

Last updated by the study team

2012-05-16

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• U.S. Oncology Research Inc. — Houston, Texas, United States
• Institute for Drug Development — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.